ZwiCoat Materials Innovations

ZwiCoat Materials Innovations (ZCMI) is a medical technology company specializing in the development of advanced surface coatings for medical implants. The company’s primary innovation is a patented, ultra-low-fouling zwitterionic (ZIP) thin-film coating that creates a permanent, covalent bond with polydimethylsiloxane (PDMS) surfaces. This technology utilizes a straightforward, single-step photoinitiated reaction, designed to be integrated into existing manufacturing processes. By acting as a durable hydration barrier, the coating is intended to significantly reduce the adhesion of non-specific proteins and prevent common complications associated with implanted biomaterials, such as inflammation, fibrotic tissue formation, and bacterial biofilm growth.

This technology is critical for improving the safety, performance, and longevity of various medical devices, including cochlear implants (CIs), endotracheal (ET) tubes, stents, and catheters. Currently, these implants are prone to foreign body responses that can lead to reduced device functionality and life-long patient complications. ZCMI’s solution aims to establish a new standard for implant biocompatibility, potentially reducing the high healthcare costs associated with device-related infections and scarring. The company has received NIH SBIR funding to validate the technical feasibility and durability of these coatings, with the goal of enabling future industry partnerships and regulatory approval.